S. Rafla
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Papers in
-
- Cerebrovascular and Carotid Artery Diseases 4
- Oncology 8
- Ear and Head Tumors 2
- Cancer Diagnosis and Treatment 2
- Co-authors
- E Henderson (2 shared papers)RR Ellison (1 shared paper)RT Silver (1 shared paper)Janet Cuttner (1 shared paper)RW Carey (1 shared paper)Howard R. Terebelo (1 shared paper)Robert M. Johnson (1 shared paper)M. Robert Cooper (2 shared papers)
- Journals
- Cancer (5 papers)Journal of Clinical Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Blood (1 paper)Radiology (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
S. Rafla
26 papers receiving 465 citations
Peers
Comparison fields: 5 of 59
- Hematology 95
- Oncology 149
- Pulmonary and Respiratory Medicine 162
- Otorhinolaryngology 15
- Oral Surgery 24
Countries citing papers authored by S. Rafla
This map shows the geographic impact of S. Rafla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rafla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rafla more than expected).
Fields of papers citing papers by S. Rafla
This network shows the impact of papers produced by S. Rafla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rafla. The network helps show where S. Rafla may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Rafla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1970 | 170 | |
| 2 | 1984 | 103 | |
| 3 | 1969 | 40 | |
| 4 | 1986 | 37 | |
| 5 | 1969 | 25 | |
| 6 | 1978 | 21 | |
| 7 | 1970 | 20 | |
| 8 | The treatment of advanced prostatic carcinoma with medroxyprogesterone. | 1974 | 13 |
| 9 | 1976 | 12 | |
| 10 | 1989 | 11 | |
| 11 | 2019 | 10 | |
| 12 | 1991 | 9 | |
| 13 | 2019 | 7 | |
| 14 | 1997 | 7 | |
| 15 | Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study. | 1984 | 7 |
| 16 | 1988 | 6 | |
| 17 | 2021 | 4 | |
| 18 | 1968 | 3 | |
| 19 | 2019 | 2 | |
| 20 | 2023 | 2 |
About S. Rafla
S. Rafla is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 28 papers that have together received 517 indexed citations. Recurring topics across this work include Salivary Gland Tumors Diagnosis and Treatment (4 papers), Cerebrovascular and Carotid Artery Diseases (4 papers), Advances in Oncology and Radiotherapy (3 papers), Advanced Radiotherapy Techniques (2 papers), Protein Degradation and Inhibitors (2 papers), Ear and Head Tumors (2 papers), Cancer Diagnosis and Treatment (2 papers) and Acute Ischemic Stroke Management (2 papers). The work is most often cited by research in Hematology (95 citations), Oncology (149 citations), Pulmonary and Respiratory Medicine (162 citations), Otorhinolaryngology (15 citations) and Oral Surgery (24 citations). S. Rafla has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include E Henderson, RR Ellison, RT Silver, Janet Cuttner, RW Carey, Howard R. Terebelo, Robert M. Johnson, M. Robert Cooper, David Prager and Robert A. Kyle. Their work appears in journals such as Cancer, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Blood and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.